Nuvectis Pharma, Inc. (NVCT)
22.86
-1.13
(-4.71%)
USD |
NASDAQ |
Sep 14, 09:58
Nuvectis Pharma Market Cap : 610.24M for Sept. 14, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 11, 2026 | 640.41M |
| September 10, 2026 | 600.37M |
| September 09, 2026 | 608.11M |
| September 08, 2026 | 640.41M |
| September 04, 2026 | 653.76M |
| September 03, 2026 | 650.55M |
| September 02, 2026 | 638.54M |
| September 01, 2026 | 615.58M |
| August 31, 2026 | 606.77M |
| August 28, 2026 | 633.47M |
| August 27, 2026 | 672.44M |
| August 26, 2026 | 667.37M |
| August 25, 2026 | 691.13M |
| August 24, 2026 | 637.20M |
| August 21, 2026 | 628.93M |
| August 20, 2026 | 623.32M |
| August 19, 2026 | 622.79M |
| August 18, 2026 | 558.19M |
| August 17, 2026 | 509.34M |
| August 14, 2026 | 506.13M |
| August 13, 2026 | 513.34M |
| August 12, 2026 | 521.62M |
| August 11, 2026 | 518.15M |
| August 10, 2026 | 503.86M |
| August 07, 2026 | 505.87M |
| Date | Value |
|---|---|
| August 06, 2026 | 502.66M |
| August 05, 2026 | 510.88M |
| August 04, 2026 | 533.16M |
| August 03, 2026 | 572.95M |
| July 31, 2026 | 570.83M |
| July 30, 2026 | 603.72M |
| July 29, 2026 | 548.81M |
| July 28, 2026 | 525.74M |
| July 27, 2026 | 518.31M |
| July 24, 2026 | 512.21M |
| July 23, 2026 | 534.49M |
| July 22, 2026 | 511.68M |
| July 21, 2026 | 506.11M |
| July 20, 2026 | 478.25M |
| July 17, 2026 | 507.70M |
| July 16, 2026 | 493.37M |
| July 15, 2026 | 519.63M |
| July 14, 2026 | 485.15M |
| July 13, 2026 | 489.13M |
| July 10, 2026 | 486.74M |
| July 09, 2026 | 503.72M |
| July 08, 2026 | 497.35M |
| July 07, 2026 | 509.29M |
| July 06, 2026 | 520.70M |
| July 02, 2026 | 519.10M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Decoy Therapeutics, Inc. | 1.543M |
| Unicycive Therapeutics, Inc. | 146.38M |
| ACADIA Pharmaceuticals, Inc. | 4.802B |
| Alnylam Pharmaceuticals, Inc. | 33.08B |
| Anika Therapeutics, Inc. | 279.17M |
Market Cap Related Metrics
| PEG Ratio | -1.322 |
| Price to Book Value | 67.19 |
| Price | 22.86 |
| Earnings Yield | -5.59% |
| PEGY Ratio | -1.322 |